After starting treatment for premenstrual dysphoric disorder (PMDD), follow-up visits help you and your clinician check whether symptoms are improving, whether side effects are manageable, and whether the plan fits your menstrual cycle and daily life. Track symptoms, period dates, doses, and side effects between visits. Contact your prescriber sooner for worsening symptoms or troublesome reactions, and seek urgent help for suicidal thoughts or if you may not stay safe.
When should you have your first follow-up appointment?
Your clinician should help you plan your first review when treatment begins. The timing depends on the treatment prescribed, your medical history, your symptoms, and any concerns that arise after starting. If you begin an antidepressant, an early review is especially useful for checking how you feel, whether the medicine is helping, and whether you are experiencing side effects.
According to the NHS guidance on antidepressants, people starting these medicines are commonly reviewed every one to two weeks initially. This is general guidance for antidepressant treatment, rather than a fixed schedule for every person receiving PMDD care. Your clinician may recommend a different interval based on your circumstances and the medicine's prescribed schedule.
Do not wait for a routine appointment if symptoms get worse, side effects become difficult to manage, or you have concerns about taking the medicine safely. Contact your prescribing clinician for advice about the next steps.
What should you track between PMDD follow-up visits?
A daily record can help you and your clinician see whether treatment is changing the pattern of symptoms across your menstrual cycle. Because PMDD symptoms are linked to the menstrual cycle, noting both symptom changes and the dates of menstruation is more useful than relying on memory at the next appointment.
The NHS information on PMDD recommends keeping a symptom diary for at least two menstrual cycles when assessing possible PMDD. Once treatment has started, continuing a diary can also help your clinician review your progress.
Useful details to record include:
- Emotional symptoms: changes in mood, irritability, anxiety, sadness, or feelings of being overwhelmed.
- Physical symptoms: changes in sleep, energy, breast tenderness, bloating, headaches, or muscle and joint discomfort.
- Daily functioning: whether symptoms affect work, school, relationships, social activities, or usual responsibilities.
- Menstrual timing: the first day of your period and the days when symptoms appear, improve, or return.
- Medication use: the prescribed dose and schedule, any missed doses, and when side effects occur.
- Other changes: any new medicines, supplements, or changes in your general health that might be relevant.
Keep the record simple enough to maintain consistently. You do not need to write a detailed account of every day. Brief notes that describe symptom patterns, their impact, and any changes after treatment can provide useful information for your review.
How will your clinician assess whether treatment is working?
Follow-up involves more than asking whether you feel better. Your clinician will consider which symptoms have changed, how much they interfere with daily life, whether improvement lasts through the expected part of your cycle, and whether side effects are acceptable. The aim is to find a treatment approach that provides meaningful relief while remaining manageable and appropriate for your health needs.
For example, emotional symptoms may improve while sleep problems or physical discomfort continue. Alternatively, you may feel better during the days before menstruation but still experience mood symptoms throughout the rest of the month. Sharing these details helps the clinician decide whether the current plan is meeting your needs or whether further assessment may be useful.
What if you are taking an antidepressant?
Selective serotonin reuptake inhibitors (SSRIs) are commonly used to treat PMDD. Depending on the prescribed plan, an SSRI may be taken every day or only during part of the menstrual cycle. The Mayo Clinic's information on PMDD describes both approaches. During follow-up, your clinician may review whether the prescribed timing is suitable, whether you have been able to take the medicine as directed, and whether your symptoms have changed.
Antidepressants used for different conditions can have different response patterns. Some effects may begin within the first couple of weeks, while fuller benefits may take longer. Your clinician can explain what to expect from your particular medicine and schedule. Do not increase, reduce, skip, or change the timing of your prescribed medicine without discussing it with your prescriber.
Which side effects should you discuss at follow-up?
Tell your clinician about new symptoms or changes that begin after starting treatment, even if they seem manageable. Depending on the medicine, antidepressant side effects may include nausea, headaches, dizziness, changes in sleep, digestive problems, or sexual difficulties. Hormonal treatments may have their own side effects, so the symptoms worth discussing depend on the treatment you use.
Some antidepressant side effects become less troublesome after the body adjusts, while others may persist. Your clinician can help weigh these effects against the benefits of treatment and decide whether monitoring, a change in the treatment plan, or another option is appropriate. If a side effect is severe, sudden, or concerning, seek medical advice promptly rather than waiting for your scheduled review.
Tell your clinician or pharmacist about other prescription medicines, over-the-counter products, and supplements you take. Some products can interact with antidepressants or other treatments. Do not stop an antidepressant suddenly or discontinue hormonal treatment without discussing the safest approach with the clinician who prescribed it.
What happens if PMDD symptoms are not improving?
Limited improvement at an early review does not automatically mean treatment has failed. Your clinician may need more information about the treatment schedule, how regularly it has been used, side effects, and changes in symptoms across the menstrual cycle. It is also important to discuss symptoms that continue outside the premenstrual period, since this pattern may prompt assessment for other or additional concerns.
If the current approach is not providing enough relief, the next step depends on your response and preferences. The American College of Obstetricians and Gynecologists describes treatment options for premenstrual disorders that include antidepressants, hormonal medicines, and other supportive approaches. A clinician may consider adjusting the existing plan, trying a different medicine, or discussing psychological treatment such as cognitive behavioural therapy (CBT).
Not every treatment change is necessary after the first review. Your clinician may recommend continued monitoring when treatment has only recently started and there are no concerning problems. However, persistent symptoms that disrupt daily life deserve further discussion. Keep attending agreed appointments so that decisions can be based on your response over time rather than a single difficult day.
When should you seek help before your next appointment?
Contact your clinician promptly if symptoms become substantially worse, you develop a concerning reaction to treatment, or you have difficulty following the prescribed schedule safely. Seek urgent medical help if you develop suicidal thoughts, urges to harm yourself, or feel unable to keep yourself safe. Do not wait for your next routine follow-up in these situations.
Antidepressants can sometimes be associated with new or worsening suicidal thoughts, particularly during the early stages of treatment. The NHS antidepressant guidance notes that people aged 24 or younger, and people who have experienced these thoughts before, may need particular attention to this risk. Anyone taking an antidepressant should report new suicidal thoughts or urges to self-harm immediately. If there is immediate danger, contact local emergency services or go to the nearest emergency department.
If you are an adolescent or supporting a young person receiving PMDD treatment, agree on a clear follow-up and safety plan with the prescribing clinician. Where appropriate, a trusted adult can help notice changes in mood or behaviour and support attendance at appointments, while respecting the young person's privacy and involving them in decisions about their care.
How can you prepare for a more useful follow-up visit?
Before the appointment, review your symptom diary and make a short note of the most important changes since treatment began. Include improvements as well as ongoing difficulties, side effects, missed doses, and questions about how or when to take your medicine. If you are using a hormonal treatment or attending CBT, record any changes in symptoms, bleeding patterns, or daily functioning that you think may be relevant.
It can also help to ask what improvement to expect, when the next review should occur, which side effects require urgent attention, and what the plan will be if symptoms remain disruptive. Agreeing on these next steps makes it easier to know what to monitor and when to seek further help. Treatment decisions should be shared between you and your healthcare professional, taking into account symptom relief, safety, and your individual needs.